Aims/hypothesis. We investigated the effect of physiological hyperinsulinaemia on global and regional myocardial blood flow and glucose uptake in five patients with Type II (non-insulin-dependent) diabetes mellitus and seven healthy control subjects. Methods. Myocardial blood flow was assessed by positron emission tomography with oxygen-15 labelled water (H 2 15 O) either before or after 1 h of euglycaemic hyperinsulinaemia. Myocardial glucose uptake was assessed by positron emission tomography and fluorine-18 labelled fluorodeoxyglucose ( 18 FDG). Results. During hyperinsulinaemia, myocardial blood flow increased from 0.91±0.03 to 1.00±0.03 ml . min -1 . g -1 in control subjects (p<0.005) and from 0.81±0.02 to 0.95±0.04 ml . min -1. g -1 in diabetic patients (p<0.0005). Corresponding glucose uptakes were 0.56±0.01 and 0.36±0.02 µmol . min -1. g -1 (p<0.0001), respectively. During hyperinsulinaemia, the regional distribution of myocardial blood flow and glucose uptake showed higher values in the septum and anterolateral wall (short axis) and in the mid-ventricle (long axis) in control subjects, and insulin action was circumscribed to these regions. In diabetic patients, the regional distribution of glucose uptake was similar; however, insulin-induced increase of myocardial blood flow was mainly directed to the postero-inferior areas (short axis) and to the base (long axis) of the heart, thus cancelling the predominance of the anterior wall observed before insulin administration. Conclusion/interpretation. These results provide evidence that insulin-mediated regulation of global myocardial blood flow is preserved in Type II diabetic patients. In contrast, the regional re-distribution of myocardial blood flow induced by insulin is directed to different target areas when compared with healthy subjects, thereby resulting in a mismatch between blood flow and glucose metabolism. [Diabetologia (2002[Diabetologia ( ) 45:1404[Diabetologia ( -1409 Keywords Insulin, diabetes, myocardial glucose metabolism, myocardial perfusion, positron emission tomography. The availability of non-invasive quantification of myocardial blood flow (MBF) with positron emission tomography (PET) has re-opened the long debated issue concerning the role of insulin in the regulation of myocardial perfusion. A better understanding of this issue carries important pathophysiological implications on the relation between insulin resistance and enhanced cardiovascular risk. In previous studies [1, 2, 3, 4, 5, 6] , the use of invasive techniques and/or anaesthesia could have introduced confounding factors, such as variable degrees of sympathetic activation and circulating NEFA concentrations. Using PET and oxygen-15 labelled water, we have shown that in healthy
The availability of non-invasive quantification of myocardial blood flow (MBF) with positron emission tomography (PET) has re-opened the long debated issue concerning the role of insulin in the regulation of myocardial perfusion. A better understanding of this issue carries important pathophysiological implications on the relation between insulin resistance and enhanced cardiovascular risk. In previous studies [1, 2, 3, 4, 5, 6] , the use of invasive techniques and/or anaesthesia could have introduced confounding factors, such as variable degrees of sympathetic activation and circulating NEFA concentrations. Using PET and oxygen-15 labelled water, we have shown that in healthy humans a small increase in resting myocardial perfusion occurs early during insulin stimulation [7] , and that the magnitude of this change seems to be larger in those segments of the heart with higher glucose consumption. It has been reported [8] that physiological hyperinsulinaemia amplifies adenosine-induced hyperaemia in healthy men. We have not found any other non-invasive studies addressing the issue of whether insulin action on MBF is preserved in insulin-resistant individuals. Previous evidence [9] has suggested a direct action of insulin by showing that, during cardiac catheterisation in patients with coronary artery disease (six of whom were hypertensive), local intracoronary insulin infusion led to an increase in coronary sinus blood flow without an increase in oxygen demand. Both coronary artery disease and hypertension are associated with insulin resistance [10, 11] . Unfortunately, comparison with a group of healthy people was not undertaken.
Our study was designed to test, non-invasively, the hypothesis that insulin regulation of myocardial perfusion could be either globally or regionally altered in patients with Type II (non-insulin-dependent) diabetes mellitus and to assess the regional match between myocardial perfusion and glucose metabolism in these patients.
Subjects and methods
Subjects. The study group consisted of five men with uncomplicated Type II diabetes and seven healthy men. Inclusion criteria for all subjects were: no history of cardiovascular disease, normal heart rate, arterial blood pressure, a normal resting electrocardiogram and echocardiogram, and an active lifestyle, including moderate exercise at least once a week; diabetic patients were undergoing regular screening at the outpatient clinic and were referred to us as being free of significant complications, which was an additional inclusion criterion for this group. Subjects participating in intense physical training programmes were excluded. All subjects were asked to consume a diet containing at least 200 g of carbohydrate for 3 days prior to the study. None of the healthy control subjects were taking any medication at the time of the study. Patients with diabetes were taking oral hypoglycaemic medications, including sulphonylureas and/or metformin, on which they were started shortly after diagnosis (12±4 years before the study). They were not taking any medication known to compromise myocardial perfusion or endothelial function.
The study was approved by the Research Ethics Committee of Hammersmith Hospital and by the UK Administration of Radioactive Substances Advisory Committee. Each subject gave their written informed consent before participating in the study.
PET scan. All scans were done in a two-dimensional imaging mode using an ECAT 931-08/12 scanner (CTI, Knoxville, Tenn., USA) with a 10.5 cm axial field of view and a resolution of 8.4×8.3×6.6 mm 3 full width at half maximum (FWHM) [12] . All studies were carried out after a 10-to 12-h fast.
After the patient was positioned correctly, a 20-min transmission scan was done after exposure of a retractable 68 Ge ring source to correct all subsequent emission data for tissue attenuation of gamma photons. Then, the patients inhaled 15 Olabelled carbon monoxide (C 15 O, 3.0 MBq/ml) for 4 min at a flow rate of 500 ml/min and a single frame scan was used to image the blood pool [11] . After allowing 10 min for decay of 15 O radioactivity, 15 O-water (740 MBq) was injected as an intravenous bolus over 20 s [11] . A primed-continuous (40 mU . m -2. min -1 ) infusion of insulin was started immediately after the first 15 O-water scan, and a 150-min euglycaemic hyperinsulinaemic clamp was carried out [11, 13] . After about an hour (65±5 min) had elapsed from the start of the clamp, a second assessment of MBF was done. Immediately thereafter 18 FDG (185 MBq) was infused over 2 min and a dynamic scan was carried out [11] .
Arterialised blood was collected for biochemistry. Glucose was measured through the glucose oxidase reaction and plasma samples were frozen at -20°C for subsequent insulin and NE-FA assay.
Image processing. All sinograms were corrected for tissue attenuation and reconstructed through standard reconstruction algorithms. Image generation and model-fitting computations were done on a SUN Ultra 10 workstation (Sun Microsystems, Mountain View, Calif., USA) as described previously [11] by using dedicated software running in the MATLAB programming language (The MathWorks, Natick, Mass., USA).
Regions of interest (ROIs).
All images were re-sliced along the short axis and the free wall of the left ventricle was divided according to the 16-segment model recommended by the American Society of Echocardiography [14] . Regions of interest (ROIs) were drawn on short-axis images. The basal and mid sections of the left ventricular wall were subdivided into six ROIs, corresponding to antero-septal, anterior, lateral, inferior, posterior, and postero-septal walls, while four ROIs, corresponding to the anterior, lateral, inferior, and septal regions, were identified on the apical section. MGU and MBF were quantified [11] in matching ROIs. A lumped constant of 1.0 was used to derive MGU [15] .
Statistical analysis. Differences in paired data were evaluated using the Student's t test for single repeated measurements. One-way ANOVA was used for unpaired group comparisons. All data are given as means ± SEM. Significance was set at a p value of less than 0.05.
Results
The diabetic patients were older than the control subjects but otherwise well matched (for BMI, arterial blood pressure, heart rate, and left ventricular ejection fraction) ( Table 1) . Fasting plasma glucose concentrations were higher in the diabetic patients but euglycaemia was achieved during the clamp in both groups. Fasting plasma NEFA concentrations were similar in both groups, as was insulin-mediated suppression of circulating NEFA.
Whole myocardium. Mean insulin-mediated myocardial glucose uptake (MGU) was lower in diabetic than healthy subjects (p<0.0001) (Fig. 1) .
Baseline and clamp MBF values were similar in the two groups, and insulin stimulated a comparable in-crease in MBF in both diabetic and control subjects (0.09±0.34 vs 0.13±0.29 ml . min -1. g -1 , p=NS) (Fig. 2) . Short axis regions. In the control subjects and diabetic patients, the regional distribution of insulin-stimulated MGU showed higher values in the septum and anterolateral wall compared with the postero-inferior wall (p<0.001 and p<0.05, respectively) (Fig. 3) . In diabetic patients, MGU was similarly reduced in each myocardial wall (p<0.0001 vs control subjects) (Fig. 4A) .
In healthy subjects, the regional distribution of MBF matched that of MGU under both fasting (septum-anterolateral 0.95±0.26 ml . min -1. g -1 vs postero-inferior 0.82±0.29 ml . min -1. g -1 , p<0.05) and clamp conditions (septum-anterolateral 1.09±0.30 ml . min -1. g -1 vs postero-inferior 0.84±0.27 ml . min -1. g -1 , p<0.0001) (Fig. 3) . In addition, the insulin-induced increase of MBF above basal values across myocardial regions followed the same pattern of insulin-stimulated MGU (Fig. 4C) , and was higher in the septum and antero-lateral wall (p<0.002 vs basal). In diabetic patients, basal MBF was higher in the anterior wall than in the rest of myocardial perimeter (p<0.05) (Fig. 3) . During the clamp however, the increase of MBF above basal values predominantly involved the postero-inferior regions (p<0.01 vs basal), thus cancelling out any difference among regions (Fig. 4C) . Therefore, during the 18 FDG (right panels) distribution in a healthy control (top panels) and a diabetic subject (bottom panels), documenting homogeneous reduction of insulin-mediated FDG uptake in all myocardial walls of the diabetic patient. H 2 15 O and insulinmediated FDG uptake show regional prevalence of the septum and antero-lateral walls clamp MBF increased more where MGU tended to be lower and vice versa, leading to a mismatch between insulin-mediated MBF and glucose uptake.
Long axis segments. MGU was reduced in diabetic patients along all long axis segments (p<0.0001 vs control subjects) (Fig. 4B) . In the healthy subjects, basal MBF was similar among long axis segments; in diabetic patients, there was a significant prevalence in the apex and mid-ventricle (p<0.02). During the clamp, MBF increased in the apex and mid-ventricle in the control subjects, (p<0.05) (Fig. 4D) . In contrast, MBF was evenly distributed in all segments in diabetic patients, as the increase over baseline values mainly involved the basal segment of the ventricle (p<001).
In summary, insulin affected the re-distribution of MBF in an opposite fashion in the two groups in that it increased the match between MGU and MBF in control subjects, but uncoupled MGU and MBF in diabetic patients.
Discussion
The present data show that insulin causes a comparable rise in total myocardial perfusion in healthy subjects and in Type II diabetic patients. As previously shown in healthy people [7] , this effect was not uniformly distributed across myocardial regions in either of the two groups. Although the magnitude of change followed the heterogeneous metabolic requirements observed across myocardial regions in the control group, the two functions appeared to lack such coordination in diabetic patients.
Whereas methodological diversities might explain some previously reported discrepancies, more recent studies are consistent in supporting a vaso-active effect of insulin in the whole myocardium [7, 8, 9] . Based on the recent study showing that in healthy subjects physiological hyperinsulinaemia potentiates the coronary vasodilatation induced by maximal adenosine stimulation, the term insulin-mediated 'coronary flow reserve' can be introduced [8] .
Myocardial glucose uptake was impaired in our diabetic patients during the clamp, which proves that the insulin resistance of Type II diabetes extends to cardiac cells, as suggested by other authors [16, 17] . Previous evidence also indicates that myocardial insulin resistance might be overcome by raising hyperinsulinaemia to supraphysiological concentrations in patients with uncomplicated Type II diabetes [18] . Although coronary artery disease (CAD) can be associated with myocardial insulin resistance [11] and sub-clinical CAD cannot be completely excluded in our patients, our inclusion criteria rule against this possibility; nevertheless, sub-clinical cardiovascular disease has not been related with myocardial insulin resistance. Reduced coronary flow reserve and endothelial dysfunction are commonly observed in Type II diabetes [19] . Though still controversial, the loss of insulin-stimulated vasodilatation in the skeletal muscle of insulin resistant patients has been causally related to the impairment of glucose uptake found in the skeletal muscle of these patients [20] . In our diabetic patients, myocardial insulin resistance was not associated with an obvious impairment in insulin-mediated vasodilatation in the heart as a whole; thus, there is no evidence of a causal relation to the reduced glucose uptake observed during the clamp in these patients.
In line with previous reports [21, 22] , our results emphasize the concept that considering the myocardium as a uniformly functioning tissue might be misleading. Consequently, each portion of the left ventricular wall might have metabolic and perfusion needs which are specific in magnitude [23, 24] . Our results support this theory. Despite an apparently normal insulin regulation of global myocardial perfusion, our study shows that regional selectivity of insulin action was impaired in diabetic patients. In healthy subjects, insulin action on both myocardial perfusion and glucose metabolism was more pronounced in the septum and antero-lateral walls, while blood flow was almost unaffected in the posterior and inferior walls during the clamp. This does not imply that perfusion would directly influence glucose uptake or vice versa. However, it does suggest that insulin contributes to tighten flow/metabolism match across myocardial regions. In diabetic patients, the pattern of glucose uptake across myocardial regions was similar to that of the control subjects, which entails that the degree of impairment of insulin action was comparable through all the left ventricular walls. On the contrary, myocardial perfusion was preferentially stimulated in the posterior and inferior walls, thus leading to a flow/metabolism uncoupling. Similarly, myocardial blood flow along the cardiac long axis was stimulated in the more proximal portion during the clamp in diabetic patients, which was at variance with the mid-ventricular predominance occurring in the control subjects.
We did not design our study to investigate mechanisms of action of insulin in the myocardium. Changes in cardiac workload, which are reflected by the rate-pressure product, induce adjustments of myocardial flow to metabolic needs. We did not observe changes in global myocardial performance. The age difference observed between the two study groups did not affect the capability of insulin to enhance myocardial perfusion in older Type II diabetic subjects, which is in line with previous evidence showing that age is not an independent determinant of myocardial perfusion [25] and does not induce changes in its regional distribution. In normal subjects, physiological hyperinsulinaemia can modulate central neural control directed to the heart by inducing vagal withdrawal paralleled by a slight sympathetic activation [26, 27, 28] . This dual action on the regional autonomic control could explain the overall increase of MBF, and the predominance of sympathetic innervation in the antero-septal ventricular wall [29] could account for the preferential increase of MBF in this region. Of interest, recent radionuclide studies have shown that signs of autonomic neuropathy are present at a very early stage in the heart of patients with diabetes, when microvascular complications are not yet clinically detectable [30] . In keeping with our results in the diabetic patients, the posterior and the proximal portions of the left ventricular wall seem to be predominantly, or more precociously, affected.
In conclusion, physiological hyperinsulinaemia increased global myocardial perfusion by approximately 10 to 15% both in healthy subjects and Type II diabetic patients. The re-distribution of MBF however, was targeted to different regions in the two groups, whereas that of MGU was similar. Consequently, the concordance between flow and glucose uptake was tightened in control subjects and weakened in diabetic patients.
